# Clinical trials recruiting in Kuwait: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials recruiting or not yet recruiting with a site in Kuwait, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Kuwait: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/kuwait

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 16, 2026 | NCT07822113 | A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding Dysfunction | Jaber Al Ahmad Al Sabah Hospital | Phase 2 | Not yet recruiting | Voiding Dysfunction, Female LUTS | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822113) |
| August 14, 2026 | NCT07766538 | Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait | Sponsor not shown (see the record) | Not applicable | Recruiting | Lung Cancer, Lung Neoplasms | 590 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766538) |
| June 16, 2026 | NCT07650773 | CHARM Hepatocellular Carcinoma MEA Study | AstraZeneca | Observational | Recruiting | HepatoCellular Carcinoma | 4,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650773) |
| May 8, 2026 | NCT07574723 | Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity | Dasman Diabetes Institute | Not applicable | Recruiting | Obesity | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07574723) |
| January 22, 2026 | NCT07361146 | A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized... | Sponsor not shown (see the record) | Not applicable | Recruiting | End-stage Renal Disease (ESRD), Chronic Kidney Disease, Hemodialysis Patients, Physical Rehabilitation During Dialysis | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07361146) |
| December 4, 2025 | NCT07263646 | The Effect of Balance-focused Exercise Programme in Enhancing the Solus-muscle Activation During Gait Initiation for People With Parkinson... | Ministry of Health, Kuwait | Not applicable | Not yet recruiting | Parkinson Disease, Gait Disorders, Gait Balance | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263646) |
| October 14, 2025 | NCT07215975 | A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East | Bristol-Myers Squibb | Observational | Recruiting | β-thalassemia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07215975) |
| July 31, 2025 | NCT07096908 | Tirzepatide Use in People With Obesity and Type 1 Diabetes | Dasman Diabetes Institute | Phase 4 | Recruiting | Type1diabetes, Obesity | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07096908) |
| July 15, 2025 | NCT07065344 | A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients... | AstraZeneca | Observational | Recruiting | Hematology, Diffused Large B Cell Lymphoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07065344) |
| June 26, 2025 | NCT07038473 | Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) | Sanofi | Not applicable | Recruiting | Type 1 Diabetes | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07038473) |
| May 22, 2025 | NCT06984133 | Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes | Dasman Diabetes Institute | Not applicable | Recruiting | Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus (T1DM) | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06984133) |
| April 10, 2025 | NCT06922656 | Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in... | Dasman Diabetes Institute | Phase 4 | Not yet recruiting | Type 1 Diabetes | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06922656) |
| March 20, 2025 | NCT06885736 | LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy | Dasman Diabetes Institute | Not applicable | Recruiting | Obesity | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885736) |
| November 19, 2024 | NCT06694246 | Improving Outpatient Endometrial Biopsy Results | Cairo University | Observational | Recruiting | Histopathology, Screening Tool, Techniques | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06694246) |
| June 5, 2024 | NCT06442930 | EXtubation Related Complications - the EXTUBE Study (EXTUBE) | University Health Network, Toronto | Observational | Recruiting | Extubation | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06442930) |
| April 19, 2024 | NCT06374875 | Fibrosis Lessens After Metabolic Surgery | The Cleveland Clinic | Phase 4 | Recruiting | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06374875) |
| March 18, 2024 | NCT06314282 | INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use | AstraZeneca | Observational | Recruiting | Systemic Lupus Erythematosus (SLE) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06314282) |
| November 3, 2023 | NCT06115876 | Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program | Dasman Diabetes Institute | Observational | Recruiting | Diabetes Mellitus Type 2, Diabetes Mellitus Type 1, NAFLD - Nonalcoholic Fatty Liver Disease, PreDiabetes | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06115876) |
| January 9, 2023 | NCT05675098 | Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy | Kuwait University | Early phase 1 | Not yet recruiting | Neurodevelopmental Disorders, Cerebral Palsy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05675098) |
| December 8, 2022 | NCT05642260 | Effects of Fall Prevention Program on the Number of Falls Among Elderly Following Total Knee Replacement | Ministry of Health, Kuwait | Not applicable | Recruiting | Fall, Osteo Arthritis Knee, Total Knee Replacement | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05642260) |
| June 24, 2022 | NCT05430971 | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | Immune Oncology Research Institute | Observational | Recruiting | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05430971) |
| February 1, 2012 | NCT01524276 | Product Surveillance Registry | Medtronic | Observational | Recruiting | Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders... | 100,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01524276) |
| August 1, 2006 | NCT00358943 | International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry | Genzyme, a Sanofi Company | Observational | Recruiting | Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide... | 12,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00358943) |
| December 30, 2005 | NCT00271180 | Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products | Medtronic | Observational | Recruiting | Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00271180) |
| October 4, 2005 | NCT00231400 | Pompe Disease Registry Protocol | Genzyme, a Sanofi Company | Observational | Recruiting | Glycogen Storage Disease Type II, Pompe Disease | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00231400) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Dasman Diabetes Institute | Kuwait City | 7 |
| Amiri Hospital | Kuwait City | 2 |
| Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center | Hawalli | 1 |
| Kuwait University | Kuwait City | 1 |
| Adan hospital | Kuwait | 1 |
| Lung Cancer Screening Clinic, Chest Diseases Hospital | Kuwait City | 1 |
| Physical Medicine and Rehabilitation Center, Kuwait | Kuwait City | 1 |
| Department of hematology, Kuwait Cancer Control Center | Kuwait City | 1 |
| Physical Medicine and Rehabilitation Hospital | Kuwait City | 1 |
| Alrazi orthopedic hospital | Kuwait City | 1 |
| Farwaniya Hospital | Kuwait City | 1 |
| Jaber Al Ahmad Al Jaber Al Sobah Hospital | Kuwait City | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 3 |
| Not applicable | 8 |
| Observational | 13 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 4 |
| Diabetes Mellitus, Type 1 | 4 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Carcinoma, Hepatocellular | 1 |
| Kidney Failure, Chronic | 1 |
| Renal Insufficiency, Chronic | 1 |
| Liver Cirrhosis | 1 |
| Fabry Disease | 1 |
| Angiokeratoma | 1 |
| Urologic Diseases | 1 |
| Nervous System Diseases | 1 |
| Cardiovascular Diseases | 1 |
| Digestive System Diseases | 1 |
| Intracranial Aneurysm | 1 |
| Renal Insufficiency | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Prediabetic State | 1 |
| Weight Loss | 1 |
| Gaucher Disease | 1 |
| Lung Neoplasms | 1 |
| Ketosis | 1 |
| Hypoglycemia | 1 |
| Parkinson Disease | 1 |
| Mobility Limitation | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Dasman Diabetes Institute | 6 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| [Medtronic](https://specstream.ai/data/clinical-trials/company/medtronic) | 2 |
| Ministry of Health, Kuwait | 2 |
| University Health Network, Toronto | 1 |
| The Cleveland Clinic | 1 |
| Cairo University | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| Immune Oncology Research Institute | 1 |
| Kuwait University | 1 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| Jaber Al Ahmad Al Sabah Hospital | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Industrial cleaning companies in the United States](https://specstream.ai/data/businesses/industrial-cleaning-companies/united-states)
- [Fire and water damage restoration companies in the United States](https://specstream.ai/data/businesses/fire-and-water-damage-restoration-companies/united-states)
- [Customs brokers in the United States](https://specstream.ai/data/businesses/customs-brokers/united-states)
- [Bottled water companies in the United States](https://specstream.ai/data/businesses/bottled-water-companies/united-states)
- [American restaurants in the United States](https://specstream.ai/data/businesses/american-restaurants/united-states)
- [Tires manufacturers in the United States](https://specstream.ai/data/businesses/tires-manufacturers/united-states)
